This is mechanistic clinical trial that evaluates the role of one of the glutamate receptors (mGluR5) in cognitive behavioral therapy for insomnia (CBT-I) as a common pathway in improving sleep and depression.
Phase:
PHASE4
Details
Lead Sponsor:
Stony Brook University
Collaborators:
National Institute of Mental Health (NIMH) National Institutes of Health (NIH)
Treatments:
Cognitive Behavioral Therapy Magnetic Resonance Spectroscopy